Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Tixagevimab-cilgavimab is used for pre-exposure prophylaxis of COVID-19 in immunocompromised patients, though in vitro data has shown reduced neutralizing activity against SARS-CoV-2 Omicron subvariants.
Methods: We performed genomic sequencing of SARS-CoV-2 isolated from patients diagnosed with COVID-19 following tixagevimab-cilgavimab. Resistance-associated substitutions were used to generate a predicted phenotypic susceptibility analysis to tixagevimab-cilgavimab and bebtelovimab. Clinical data collected from these patients included SARS-CoV-2 immunization status, COVID-19-directed therapies, and outcomes.
Results: SARS-CoV-2 genome sequencing was performed in 25 patients. SARS-CoV-2 Omicron BA.2 was the most common identified subvariant. All patients had viral isolates with spike codon substitutions associated with reduced susceptibility to tixagevimab-cilgavimab; their predicted phenotypic analysis showed a >2-fold reduced susceptibility to tixagevimab-cilgavimab. Two patients had viral isolates with spike codon substitutions (K444N and G446D) associated with highly reduced susceptibility to bebtelovimab, although all the viral isolates had <2-fold reduced susceptibility based on predicted phenotypic analysis. Sixteen patients received rescue therapy with bebtelovimab, but one patient with BA.2 subvariant harboring K444N mutation died of COVID-19-related complications. Five patients received other COVID-19 therapies and survived. Four had mild or asymptomatic COVID-19 with an uncomplicated course despite not receiving any additional therapy.
Discussion: Multiple SARS-CoV-2 Omicron spike codon substitutions that correlated with reduced susceptibility to tixagevimab-cilgavimab were identified in patients with COVID-19 after receiving this monoclonal antibody. Most patients had an uncomplicated course. The identification of spike codon substitutions conferring resistance to bebtelovimab highlights the importance of performing genomic surveillance to identify new resistant SARS-CoV-2 variants.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877152 | PMC |
| http://dx.doi.org/10.1016/j.jcv.2023.105382 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cryo-EM structure of a type VI secretion system-delivered membrane-depolarizing toxin involved in bacterial antagonism.
Cell Rep
September 2025
Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8S 4K1, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON L8S 4K1, Canada; David Braley Center for Antibiotic Discovery, McMaster University, Hamilton, ON L8S 4K
Many Gram-negative bacteria use type VI secretion systems (T6SSs) to deliver toxic effector proteins into neighboring cells. Proteins in the VasX toxin family form ion-permeable channels in the bacterial cytoplasmic membrane that dissipate the proton motive force, thereby interfering with essential physiological processes. However, the structure of any VasX family effector has remained unknown.
View Article and Find Full Text PDFMultiFusion2HPO: A Multimodal Deep Learning Approach for Enhancing Human Protein-Phenotype Association Prediction.
IEEE Trans Comput Biol Bioinform
September 2025
Accurately identifying associations between human genes (proteins) and clinical phenotypes is critical for advancing drug development and precision medicine. While the human phenotype ontology (HPO) standardizes clinical phenotypes, current computational approaches for predicting human protein-phenotype associations suffer from two limitations: (1) underutilization of multimodal protein-related information and (2) lack of state-of-the-art deep learning representations tailored to diverse data modalities, such as text and sequence. To overcome these limitations, we introduce MultiFusion2HPO, a novel multimodal model that integrates diverse features and advanced learning methods from multiple data sources to enhance the prediction of human protein-HPO associations.
View Article and Find Full Text PDFIntegrative analysis identifies FERMT3 as a key regulator of metabolic reprogramming in keloid scarring and metabolic syndrome.
Funct Integr Genomics
September 2025
Department of Plastic Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
Keloid scarring and Metabolic Syndrome (MS) are distinct conditions marked by chronic inflammation and tissue dysregulation, suggesting shared pathogenic mechanisms. Identifying common regulatory genes could unveil novel therapeutic targets. Methods.
View Article and Find Full Text PDFThe evolution of extreme sound frequencies in bird songs.
Evolution
September 2025
Behavioural Ecology Group, Department of Biology, University of Copenhagen, Denmark.
Bird songs differ widely among species and can show peculiar phenotypes, such as extreme or unusual sound frequencies for a species' body size. Although birds can modulate sound frequency, size-related limitations prevent vocalizing efficiently (i.e.
View Article and Find Full Text PDFChronotype and psychopathology: insights from a genetically informative design.
Sleep
September 2025
Department of Psychology, Royal Holloway, University of London, London, United Kingdom.
Study Objectives: Chronotype has been linked to a wide variety of psychiatric conditions. In particular, evening chronotype could be a transdiagnostic risk factor for different mental health difficulties. In this study we examine how chronotype relates to psychopathology and whether it can be conceptualised as part of the global construct of psychopathology (p-factor) by studying the genetic and environmental overlap between these variables.
View Article and Find Full Text PDF